Congress Weighs Value Of Pediatric Exclusivity
Legislation in Congress would lower the amount of market exclusivity that drug makers are awarded for pediatric testing of their drugs, a development the U.S. Food and Drug Administration opposes....To view the full article, register now.
Already a subscriber? Click here to view full article